Zuranolone, which will be marketed under the brand name Zurzuvae, is the first pill developed specifically to treat postpartum depression and maternal mental health experts say it has the potential to completely transform how the condition is treated.
Amy Bingham suffered from postpartum depression in 2018 after giving birth to her son, Benjamin. She received the new drug, zuranolone, in a clinical trial…